Donepezil vs Durvalumab

Donepezil vs Durvalumab: Overview

This comparison examines the pharmacological differences between Donepezil and Durvalumab.

Mechanism of Action

Donepezil: Reversible acetylcholinesterase inhibitor.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Donepezil — 70 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Donepezil — C24H29NO3.

Molecular Weight: Donepezil — 379.4920 g/mol.

Type: Donepezil — Small molecule; Durvalumab — Antibody.